These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1693371)

  • 21. The management of hyperthyroidism due to Graves' disease in the former USSR in 1991: results of a survey.
    Gerasimov G; Judenitch O; Zdanova E; Jurieva N; Korostishevskaja I; Mushinskaja K; Dedov I; Glinoer D
    J Endocrinol Invest; 1992; 15(7):513-7. PubMed ID: 1360021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Graves' disease in the elderly].
    Iitaka M
    Nihon Rinsho; 2006 Dec; 64(12):2312-6. PubMed ID: 17154098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 2011 survey of clinical practice patterns in the management of Graves' disease.
    Burch HB; Burman KD; Cooper DS
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.
    Sabri O; Zimny M; Schulz G; Schreckenberger M; Reinartz P; Willmes K; Buell U
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1229-33. PubMed ID: 10199759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age and gender predict the outcome of treatment for Graves' hyperthyroidism.
    Allahabadia A; Daykin J; Holder RL; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1038-42. PubMed ID: 10720036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial.
    Bonnema SJ; Bennedbaek FN; Veje A; Marving J; Hegedüs L
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4439-44. PubMed ID: 15356044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy after definitive treatment for Graves' disease--does treatment choice influence outcome?
    Elston MS; Tu'akoi K; Meyer-Rochow GY; Tamatea JA; Conaglen JV
    Aust N Z J Obstet Gynaecol; 2014 Aug; 54(4):317-21. PubMed ID: 24576228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?
    Kobe C; Weber I; Eschner W; Sudbrock F; Schmidt M; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(4):153-6. PubMed ID: 18690374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of Graves' disease: current views and controversies].
    Orgiazzi J
    Presse Med; 2011 Dec; 40(12 Pt 1):1155-62. PubMed ID: 22078090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.